Rankings
▼
Calendar
CRMD Q1 2018 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena
CRMD
CorMedix Inc.
$518M
Q1 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$23,210
-41.3% YoY
Gross Profit
-$5,365
-23.1% margin
Operating Income
-$10M
-43898.4% margin
Net Income
-$10M
-43882.5% margin
EPS (Diluted)
$-0.68
QoQ Revenue Growth
-74.9%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$373,293
Balance Sheet
Total Assets
$10M
Total Liabilities
$9M
Stockholders' Equity
$840,692
Cash & Equivalents
$8M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$23,210
$39,559
-41.3%
Gross Profit
-$5,365
-$54,012
+90.1%
Operating Income
-$10M
-$8M
-33.7%
Net Income
-$10M
-$8M
-34.1%
← FY 2018
All Quarters
Q2 2018 →